Alessandro Bitto

• University of Washington

  Senior scientist

Sources: reporter.nih.gov

• National Institute of Diabetes and Digestive and Kidney Diseases

  K01, Activation of C/EBP-β by mitohormesis as a therapy for obesity, K01DK128128, 2022–2027, 3 Mar 2026

• National Institute of Neurological Disorders and Stroke

  R21, Metabolic treatment of neurological mitochondrial disorders, R21NS136915, 2024–2027, 10 Apr 2025

• National Institute on Aging

  R56, Multimodal control of mitochondrial energetics to shape biological aging, R56AG082916, 2023–2025, 18 Jul 2023

Sources: reporter.nih.gov